Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSX-V: $BEER.V), (CSE: $DIXI_U.C) (OTC: $DXBRF), Wana Brands
Delta, Kelowna, BC –May 28, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/05281BEER-DIXI-DXBRF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements and I interview our second Wana Brand’s athlete, ultra-marathon runner Flavie Dokken.
Dixie Brands Inc. (CSE: DIXI.U) (OTC: DXBRF), one of the cannabis industry's leading consumer packaged goods (CPG) companies, has announced that one of its canine supplement products will form the basis of a clinical trial by the Veterinary Clinical Investigations Center at the University of Pennsylvania School of Veterinary Medicine (Penn Vet). The trial will evaluate the effectiveness of "Mobility," a hemp-based natural supplement developed by Dixie subsidiary Therabis, to relieve symptoms of joint immobility in dogs.
Penn Vet's clinical trial will be led by principal investigator Dr. Kimberly Agnello. Dogs known to be suffering from inflammation secondary to osteoarthritis will be studied to determine whether those who receive the Therabis supplement achieve better outcomes than untreated dogs. One group of dogs will receive the formula for a proprietary veterinarian-specific formula Therabis product; a second group will receive Cannabidiol alone which previous studies have shown may have benefit in osteoarthritic dogs; a control group will receive a placebo. Study designers are targeting inclusion of up to 20 dogs in each group. The design of this study will provide valuable data defining the synergistic potential of the additional ingredients in the Therabis formula.
The clinical trial is among the first scientific studies of cannabinoid therapy for pets, and is believed to be the largest-scale trial commenced to date. It is also believed to be the first major double-blind trial, meaning neither the researchers nor the dog owners are aware of which subjects are receiving the placebo or the other two interventions. The study design incorporates physical tests to establish quantitative measures of effectiveness. In studying dogs' front leg joints rather than the more commonly studied hips, the trial's results can be readily extrapolated into other joints since the inflammatory process is equivalent. Results are anticipated within approximately 12 months, and are expected to be published in a veterinary medicine journal.
"We are honored to have a Therabis product selected by the world-renowned experts at Penn Vet for their first major study of the effects of natural hemp oil to reduce joint pain in dogs," said Dr. Stephen M. Katz, co-founder of Therabis. "Our experience in my clinic has shown that cannabidiol (CBD) is an effective treatment in reducing inflammatory response. We have a passion for improving dogs' quality of life, and we look forward to learning all we can about therapeutic methods to achieve this."
Hill Street Beverage Company Inc. (TSX-V: BEER), announced that it has signed a binding Letter of Intent to acquire OneLeaf Holding Corp., the parent company of OneLeaf Cannabis Corp., an "evidence package" stage applicant to become a licensed cannabis cultivator and processor, in an all share transaction. The Company also announces a proposed non-brokered private placement of units for gross proceeds of up to $5 million.
Both Hill Street and OneLeaf believe that cannabis beverages will expand consumption of cannabis beyond just the consumer base willing to smoke or vape products. By combining Hill Street's award-winning alcohol-free beverages with OneLeaf's access to an award-winning and unique catalogue of cannabis genetics, the combined company will have the ability to become a leader in the infused beverages market, in addition to offering differentiated traditional cannabis products.
"The OneLeaf team has built a world class, 48,200 square foot facility, built to EU GMP standards, that will house growing, extraction, and infusion. It will house the infusion, bottling, and canning of our beverages under one roof. Their catalogue of over 700 distinct cannabis cultivars, which have been collected and cultivated by the founders, includes a collection of Cannabis Cup award-winning cultivars and a diverse selection of landrace varietals. We anticipate that OneLeaf's elite genetics, which include many cultivars not legally available anywhere else, will pair perfectly with our beverages to provide unique attributes and experiences for our consumers," said Terry Donnelly, Hill Street's Chairman and CEO. "We believe the integration of OneLeaf and Hill Street will make for a powerful force in the market, and positions Hill Street to become a leading producer of infused beverages and other cannabis products."
"Hill Street's beverages have already set themselves apart on the world stage," said Trevor Green, CEO of OneLeaf. "No other alcohol-free beer and wine producer has won as many major world championship competitions as Hill Street. With a complete portfolio of beverages ready for infusion, plus their demonstrated expertise in private label and branded beverages, we believe the OneLeaf facility will become a landmark in the industry, and the source of the finest cannabis infused beverages and other cannabis products in the market. With our world class cultivation and extraction capabilities, we will be able to produce unique cannabis cultivars to match both beverage and cannabis consumption occasions and experiences, whether they are adult format, nutraceutical, sport-recovery, wellness, or even prescription drug products."
Cannabis beverages are the fastest growing segment of the market in US states where they are legal, according to Headset/Nielsen, growing at up to 61% in the past year. Each of Hill Street and OneLeaf believe there is a significant opportunity to grow their brands, as well as provide co-packing services to many companies wishing to enter the cannabis beverage market but who do not wish to operate their own packaging and production facilities. This includes major multinational beverage companies, international cannabis companies looking to enter the highly regulated Canadian market, and licensed producers looking to produce beverages using their own cannabis extracts.
Freedom Cannabis Inc, a Licensed Producer, is installing a state-of-the-art solar array at its 126,000 square foot facility in Acheson, Alberta, located 20 kilometres west of Edmonton. The 1,830 kW solar array, supplied by ENMAX, will be Canada's largest rooftop solar install to-date.
Cannabis grow facilities consume a great deal of power. The cannabis intel firm New Frontier Group noted that in 2017, cannabis growers in the US used enough electricity to power 1.7 million homes, amounting to about 1 per cent of the entire energy consumption of the United States. And those numbers are only expected to grow.
"We're aware of the ecological footprint that comes with cultivating cannabis and we want to ensure we do our part to protect the environment. This is just our first step in becoming an industry leader with a commitment to sustainable initiatives," says Troy Dezwart, Executive Director and Co-Founder of Freedom Cannabis.
The solar installation in Acheson is part of Freedom Cannabis's overall commitment to reducing its impact on the environment. The company incorporates water remediation programs in its growing process, with the intention of minimizing waste. It is also exploring BIO fuel alternatives and environmentally friendly packaging options to further reduce its carbon footprint.
Based on current demands, the installation is expected to reduce electricity costs by approximately $200,000 - $300,000 annually and the installation of the array is expected to be completed by August 2019 and is part of the company's plan to more than quadruple production by spring 2020.
"Freedom Cannabis is setting a positive environmental precedent in their industry and ENMAX is proud to support this organization in delivering on their environmental commitments," says Jason Atkinson, Director of Solar Operations at ENMAX, facilitators of the array. Headquartered in Calgary, Alberta, ENMAX makes, moves and sells electricity to residential, small business and large commercial customers. To date, they've facilitated 50 per cent of Alberta's total grid-connected solar.
Speaking with Wana Brand’s athlete and ultra-marathon runner Flavie Dokken, she explained how she utilizes the health benefits of cannabis as a natural alternative for recovery and pain relief among the athletic community and beyond.
“Having already utilized cannabis for recovery and pain relief before becoming a Wana Brand Athlete, I am thrilled to continue our relationship for a second year,” Dokken said. “Being a Wana ambassador has been immensely rewarding. I want to educate more people on how cannabis can improve the quality of their workout. It has certainly helped me be a better athlete.”
A former bodybuilder and a U.S. Army Veteran, Dokken’s many competitive accomplishments include completing multiple marathons and ultramarathons such as placing 3rd in the Running Up For Air (RUFA) - Colorado on March 9 after running up and down Granite Peak for three hours and three loops for a total 2,700 foot gain and 9.3 miles. Additionally, Dokken came in 4th out of 110 runners in the Mad Moose Pueblo Half Marathon in February (pictured), which she completed in under 1 hour and 35 minutes.
Dokken will run as a Wana Athlete brand ambassador in 2019 events including Collegiate Peaks Trail Run (May 4, Buena Vista, Colorado); Speedgoat 50K (July 20, Alta, Utah); Run the Rut 50K (Sept. 1, Big Sky, Montana); and the Mad Moose Sage Burner Trail Race 28K (Oct. 26, Gunnison CO).
Many athletes have found that marijuana can be used as a compliment to their training and recovery programs, and it provides symptom relief without the negative side effects that painkillers and prescription drugs can have. It has been reported that Indica strains rich in CBD help athletes with pain management, relaxation, decreased anxiety and improved sleep quality.
“Resiliency. Honesty. Integrity. Respect. Optimism. Emotional Intelligence. Creativity. Transparency. Directness. These are our values and reflect Flavie’s values – which were made all the more tangible over the past year,” said Nancy Whiteman, Founder and CEO of Wana Brands. “She knows first-hand how cannabis is a tool for recovery, and she authentically advocates for the use of cannabis as a natural remedy among athletes and exercise enthusiasts alike.”
As cannabis becomes even more mainstream, an increasing number of athletes are advocating for the use of the herb as a safe and natural alternative. As a Wana Athlete brand ambassador, Dokken exemplifies how cannabis can be used as an aid in recovery. Together, Wana Brands and Dokken will continue to work to educate the athletic community and beyond on how cannabis can elevate their experience and allow them to enjoy their passion to the fullest extent.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
